Megan L. Taylor
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Megan L. Taylor has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
- Jay Shendure
Department of Genome Sciences, University of Washington, Seattle, WA, USA
4 shared publications - Beth Martin
Department of Genome Sciences, University of Washington, Seattle, WA, USA
3 shared publications - Abigail E. Clyde
Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center
2 shared publications - Alison F. Feder
Department of Genome Sciences, University of Washington, Seattle, WA, USA
2 shared publications - Chengxiang Qiu
Department of Genome Sciences, University of Washington, Seattle, WA, USA
2 shared publications - Cole Trapnell
Department of Genome Sciences, University of Washington, Seattle, WA, USA
2 shared publications
Latest Publications
- Open Access
- 14 April 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (16)
Recurrent mutations drive rapid HIV escape from two broadly neutralizing antibodies in vivo
Broadly neutralizing antibodies (bNAbs) show promise for HIV treatment and prevention, but are vulnerable to resistance evolution. Comprehensively understanding in vivo viral escape from individual bNAbs is necessary to design bNAb combinations that will provide durable responses. We characterize viral escape from two such bNAbs, 10-1074 and 3BNC117, using deep, longitudinal sequencing of full-length HIV envelope ( env ) genes from study participants treated with bNAb monotherapy. Improved sequencing depth and computational evolutionary analyses permit us to identify in vivo routes and parallelism underlying HIV escape from each bNAb, providing insight into this evolutionary process. We find that 10-1074 escape is restricted to a small number of previously documented pathways seen across participants, but these escape mutations 1) emerge via extensively recurrent mutation, 2) are not equally preferred, and 3) can preexist at low frequency in intrahost viral populations before therapy, although their detection does not predict rebound timing. In contrast, 3BNC117 escape follows background-specific patterns in which specific escape mutations present in one intrahost population rarely emerge or spread in other populations, except among highly related viruses. Despite this, 3BNC117 escape mutations can still emerge recurrently within their host. Our findings map longitudinal in vivo antibody escape across 20 diverse clade B HIV intrahost populations and reveal clinically relevant resistance dynamics that highlight how combination bNAb therapies will need to contend with extensively recurring escape mutations and dependence on genetic background.
- 14 April 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (16)
Open AccessRecurrent mutations drive rapid HIV escape from two broadly neutralizing antibodies in vivo
Broadly neutralizing antibodies (bNAbs) show promise for HIV treatment and prevention, but are vulnerable to resistance evolution. Comprehensively understanding in vivo viral escape from individual bNAbs is necessary to design bNAb combinations that will provide durable responses. We characterize viral escape from two such bNAbs, 10-1074 and 3BNC117, using deep, longitudinal sequencing of full-length HIV envelope ( env ) genes from study participants treated with bNAb monotherapy. Improved sequencing depth and computational evolutionary analyses permit us to identify in vivo routes and parallelism underlying HIV escape from each bNAb, providing insight into this evolutionary process. We find that 10-1074 escape is restricted to a small number of previously documented pathways seen across participants, but these escape mutations 1) emerge via extensively recurrent mutation, 2) are not equally preferred, and 3) can preexist at low frequency in intrahost viral populations before therapy, although their detection does not predict rebound timing. In contrast, 3BNC117 escape follows background-specific patterns in which specific escape mutations present in one intrahost population rarely emerge or spread in other populations, except among highly related viruses. Despite this, 3BNC117 escape mutations can still emerge recurrently within their host. Our findings map longitudinal in vivo antibody escape across 20 diverse clade B HIV intrahost populations and reveal clinically relevant resistance dynamics that highlight how combination bNAb therapies will need to contend with extensively recurring escape mutations and dependence on genetic background.
- Open Access
Evolutionary transfer learning enables organism-wide inference of mammalian enhancer landscapes
Understanding and modeling how a single human genome concurrently encodes gene regulatory programs for thousands of cell types remains a central challenge in genomics and machine learning. Most human cell types emerge during embryonic, fetal, and pediatric development which are inaccessible to comprehensive molecular profiling. To circumvent this, we hypothesized that the mismatch in evolutionary rates between cis- acting enhancers that modulate gene expression (fast) and the trans -acting regulatory factors that specify cell types (slow) creates an opportunity for ‘evolutionary transfer learning’. Specifically, models trained to predict cell type-specific enhancers in one species should generalize to the orthologous cell types and enhancers of related species. To test this, we generated a single-cell atlas of chromatin accessibility spanning mouse embryonic day 10 (E10) to birth (P0). Using combinatorial indexing 1 , we profiled 3.9 million nuclei from 36 staged embryos, resolving genome-wide accessibility in 36 cell classes and 140 cell types. We then trained a series of multi-output deep learning models (CREsted 2 ), each addressing limitations of the preceding approach, towards the goal of genome-wide prediction of distal enhancers across major developmental lineages. An ‘evolution-naive’ model achieved strong performance on heldout peaks, but exhibited two failure modes during genome-wide inference: overprediction at tandem repeats and conflation of promoter and distal enhancer grammars. An ‘evolution-aware’ model resolved these by regrouping accessible regions based on their retention and functional coherence across mammalian evolution, but failed to generalize across species. Finally, an ‘evolution-augmented’ model, STEAM (Synteny-aware Transfer learning for Enhancer Activity Modeling), incorporated enhancer orthologs from 241 mammalian genomes (Zoonomia 3 ) in a synteny-supervised manner. This increased the effective data scale by as much as 195-fold, markedly improving generalization across mammals despite greater label noise. We applied STEAM to the genome-wide inference of cell class-specific distal developmental enhancers in humans, mice ( HumMus ) and 239 additional mammals 3 ( BabaGanoush ), i.e. 32 × 241 = 7,712 genome-wide distal enhancer prediction tracks. Together, our results unify advances in single-cell profiling, deep learning, and comparative genomics into a framework for the evolutionary transfer learning of noncoding regulatory grammars. More broadly, our work supports the view that model organisms and evolutionarily diverse genomes are indispensable resources for accelerating and enhancing the AI-enabled exploration of human biology. Note: An interactive version of this preprint, together with count matrices, CREsted models, prediction tracks, code and reproducible figures, is available at this link (ref 4 ).
Open AccessEvolutionary transfer learning enables organism-wide inference of mammalian enhancer landscapes
Understanding and modeling how a single human genome concurrently encodes gene regulatory programs for thousands of cell types remains a central challenge in genomics and machine learning. Most human cell types emerge during embryonic, fetal, and pediatric development which are inaccessible to comprehensive molecular profiling. To circumvent this, we hypothesized that the mismatch in evolutionary rates between cis- acting enhancers that modulate gene expression (fast) and the trans -acting regulatory factors that specify cell types (slow) creates an opportunity for ‘evolutionary transfer learning’. Specifically, models trained to predict cell type-specific enhancers in one species should generalize to the orthologous cell types and enhancers of related species. To test this, we generated a single-cell atlas of chromatin accessibility spanning mouse embryonic day 10 (E10) to birth (P0). Using combinatorial indexing 1 , we profiled 3.9 million nuclei from 36 staged embryos, resolving genome-wide accessibility in 36 cell classes and 140 cell types. We then trained a series of multi-output deep learning models (CREsted 2 ), each addressing limitations of the preceding approach, towards the goal of genome-wide prediction of distal enhancers across major developmental lineages. An ‘evolution-naive’ model achieved strong performance on heldout peaks, but exhibited two failure modes during genome-wide inference: overprediction at tandem repeats and conflation of promoter and distal enhancer grammars. An ‘evolution-aware’ model resolved these by regrouping accessible regions based on their retention and functional coherence across mammalian evolution, but failed to generalize across species. Finally, an ‘evolution-augmented’ model, STEAM (Synteny-aware Transfer learning for Enhancer Activity Modeling), incorporated enhancer orthologs from 241 mammalian genomes (Zoonomia 3 ) in a synteny-supervised manner. This increased the effective data scale by as much as 195-fold, markedly improving generalization across mammals despite greater label noise. We applied STEAM to the genome-wide inference of cell class-specific distal developmental enhancers in humans, mice ( HumMus ) and 239 additional mammals 3 ( BabaGanoush ), i.e. 32 × 241 = 7,712 genome-wide distal enhancer prediction tracks. Together, our results unify advances in single-cell profiling, deep learning, and comparative genomics into a framework for the evolutionary transfer learning of noncoding regulatory grammars. More broadly, our work supports the view that model organisms and evolutionarily diverse genomes are indispensable resources for accelerating and enhancing the AI-enabled exploration of human biology. Note: An interactive version of this preprint, together with count matrices, CREsted models, prediction tracks, code and reproducible figures, is available at this link (ref 4 ).
- Open Access
- 11 November 2025
- Published by Springer Nature in Nature Biotechnology
- Vol. 44 (11) , 1894-1905
A parts list of promoters and gRNA scaffolds for mammalian genome engineering and molecular recording
A standardized ‘parts list’ of sequences for genetic engineering of microbes has been indispensable to progress in synthetic biology, but few analogous parts exist for mammalian systems. Here we design libraries of extant, ancestral, mutagenized or miniaturized variants of polymerase III promoters and guide RNA (gRNA) scaffolds and quantify their abilities to mediate precise edits to the mammalian genome through multiplex prime editing. We identify thousands of parts for reproducible editing in human and mouse cell lines, including hundreds with greater activity than commonly used sequences. Saturation mutagenesis screens identify tolerated sequence variants that further enhance sequence diversity. In an application to molecular recording, we design a ‘ten key’ array that, in mammalian cells, achieves balanced activity of pegRNAs as predicted by the activity of the component parts. The data reported here will aid the design of synthetic loci encoding arrays of gRNAs exhibiting predictable, differentiated levels of activity for applications in multiplexed perturbation, biological recorders and complex genetic circuits.
- 11 November 2025
- Published by Springer Nature in Nature Biotechnology
- Vol. 44 (11) , 1894-1905
Open AccessA parts list of promoters and gRNA scaffolds for mammalian genome engineering and molecular recording
A standardized ‘parts list’ of sequences for genetic engineering of microbes has been indispensable to progress in synthetic biology, but few analogous parts exist for mammalian systems. Here we design libraries of extant, ancestral, mutagenized or miniaturized variants of polymerase III promoters and guide RNA (gRNA) scaffolds and quantify their abilities to mediate precise edits to the mammalian genome through multiplex prime editing. We identify thousands of parts for reproducible editing in human and mouse cell lines, including hundreds with greater activity than commonly used sequences. Saturation mutagenesis screens identify tolerated sequence variants that further enhance sequence diversity. In an application to molecular recording, we design a ‘ten key’ array that, in mammalian cells, achieves balanced activity of pegRNAs as predicted by the activity of the component parts. The data reported here will aid the design of synthetic loci encoding arrays of gRNAs exhibiting predictable, differentiated levels of activity for applications in multiplexed perturbation, biological recorders and complex genetic circuits.
- Open Access
Recurrent mutations drive rapid HIV escape from two broadly neutralizing antibodies in vivo
Broadly neutralizing antibodies (bNAbs) show promise for HIV treatment and prevention, but are vulnerable to resistance evolution. Comprehensively understanding in vivo viral escape from individual bNAbs is necessary to design bNAb combinations that will provide durable responses. We characterize viral escape from two such bNAbs, 10-1074 and 3BNC117, using deep, longitudinal sequencing of full length HIV envelope ( env ) genes from study participants treated with bNAb monotherapy. Improved sequencing depth and computational evolutionary analyses permit us to identify in vivo routes and parallelism underlying HIV escape from each bNAb, providing new insights into this evolutionary process. We find that 10-1074 escape is restricted to a small number of previously documented pathways seen across participants, but these escape mutations 1) emerge via extensively recurrent mutation, 2) are not equally preferred, and 3) can pre-exist at low frequency in intra-host viral populations before therapy, although their detection does not predict rebound timing. In contrast, 3BNC117 escape follows background-specific patterns in which specific escape mutations present in one intra-host population rarely emerge or spread in other populations, except among highly related viruses. Despite this, 3BNC117 escape mutations often still emerge recurrently within their host. Our findings map longitudinal in vivo antibody escape across 20 diverse clade B HIV intra-host populations and reveal clinically relevant resistance dynamics that highlight how combination bNAb therapies will need to contend with extensively recurring escape mutations and dependence on genetic background. Significance Statement: Using recently developed techniques that capture viral genetic diversity and associations between mutations at depth, we deeply sequenced HIV from two clinical trials of broadly neutralizing antibody (bNAb) monotherapies, 3BNC117 and 10-1074. We computationally characterized HIV populations longitudinally with unprecedented resolution as they escaped these therapies in people living with HIV. Intra-host tracking of individual HIV genetic backgrounds reveals extensively recurrent mutations driving escape and suggests that HIV escape routes from certain bNAbs can depend sensitively on the genetic background of the virus. Our findings highlight the difficulties in evaluating pre-treatment resistance, provide an analysis blueprint for future trials, and inform the design of emerging combination antibody therapies to maximize the likelihood of durable efficacy.
Open AccessRecurrent mutations drive rapid HIV escape from two broadly neutralizing antibodies in vivo
Broadly neutralizing antibodies (bNAbs) show promise for HIV treatment and prevention, but are vulnerable to resistance evolution. Comprehensively understanding in vivo viral escape from individual bNAbs is necessary to design bNAb combinations that will provide durable responses. We characterize viral escape from two such bNAbs, 10-1074 and 3BNC117, using deep, longitudinal sequencing of full length HIV envelope ( env ) genes from study participants treated with bNAb monotherapy. Improved sequencing depth and computational evolutionary analyses permit us to identify in vivo routes and parallelism underlying HIV escape from each bNAb, providing new insights into this evolutionary process. We find that 10-1074 escape is restricted to a small number of previously documented pathways seen across participants, but these escape mutations 1) emerge via extensively recurrent mutation, 2) are not equally preferred, and 3) can pre-exist at low frequency in intra-host viral populations before therapy, although their detection does not predict rebound timing. In contrast, 3BNC117 escape follows background-specific patterns in which specific escape mutations present in one intra-host population rarely emerge or spread in other populations, except among highly related viruses. Despite this, 3BNC117 escape mutations often still emerge recurrently within their host. Our findings map longitudinal in vivo antibody escape across 20 diverse clade B HIV intra-host populations and reveal clinically relevant resistance dynamics that highlight how combination bNAb therapies will need to contend with extensively recurring escape mutations and dependence on genetic background. Significance Statement: Using recently developed techniques that capture viral genetic diversity and associations between mutations at depth, we deeply sequenced HIV from two clinical trials of broadly neutralizing antibody (bNAb) monotherapies, 3BNC117 and 10-1074. We computationally characterized HIV populations longitudinally with unprecedented resolution as they escaped these therapies in people living with HIV. Intra-host tracking of individual HIV genetic backgrounds reveals extensively recurrent mutations driving escape and suggests that HIV escape routes from certain bNAbs can depend sensitively on the genetic background of the virus. Our findings highlight the difficulties in evaluating pre-treatment resistance, provide an analysis blueprint for future trials, and inform the design of emerging combination antibody therapies to maximize the likelihood of durable efficacy.
- Open Access
Diversified, miniaturized and ancestral parts for mammalian genome engineering and molecular recording
As the synthetic biology and genome engineering fields mature and converge, there is a clear need for a “parts list” of components that are diversified with respect to both functional activity (to facilitate design) and primary sequence (to facilitate assembly). Here we designed libraries composed of extant, ancestral, mutagenized or miniaturized variants of Pol III promoters or guide RNA (gRNA) scaffolds and quantified their ability to mediate precise edits to the mammalian genome via multiplex prime editing. We identified thousands of parts that reproducibly drive a range of editing activities in human and mouse stem cells and cancer cell lines, including hundreds exhibiting similar or greater activity than the sequences used in conventional genome engineering constructs. We further conducted saturation mutagenesis screens of canonical Pol III promoters (U6p, 7SKp, H1p) and the prime editing guide RNA (pegRNA) scaffold, which identified tolerated variants that can be superimposed on baseline parts to further enhance sequence diversity. While characterizing thousands of orthologous promoters from hundreds of extant or ancestral genomes, we incidentally mapped the functional landscape of mammalian Pol III promoter evolution. Finally, to showcase the usefulness of these parts, we designed a “ten key” molecular recording array that lacks repetitive subsequences in order to facilitate its one-step assembly in yeast. Upon delivering this 15.8 kb tandem array of promoters and guides to mammalian cells, individual pegRNAs exhibited balanced activities as predicted by the activity of component parts, despite their relocation to a single locus. Looking forward, we anticipate that the diversified parts and variant effect maps reported here can be leveraged for the design, assembly and deployment of synthetic loci encoding arrays of gRNAs exhibiting predictable, differentiated levels of activity, which will be useful for multiplex perturbation, advanced biological recorders and complex genetic circuits.
Open AccessDiversified, miniaturized and ancestral parts for mammalian genome engineering and molecular recording
As the synthetic biology and genome engineering fields mature and converge, there is a clear need for a “parts list” of components that are diversified with respect to both functional activity (to facilitate design) and primary sequence (to facilitate assembly). Here we designed libraries composed of extant, ancestral, mutagenized or miniaturized variants of Pol III promoters or guide RNA (gRNA) scaffolds and quantified their ability to mediate precise edits to the mammalian genome via multiplex prime editing. We identified thousands of parts that reproducibly drive a range of editing activities in human and mouse stem cells and cancer cell lines, including hundreds exhibiting similar or greater activity than the sequences used in conventional genome engineering constructs. We further conducted saturation mutagenesis screens of canonical Pol III promoters (U6p, 7SKp, H1p) and the prime editing guide RNA (pegRNA) scaffold, which identified tolerated variants that can be superimposed on baseline parts to further enhance sequence diversity. While characterizing thousands of orthologous promoters from hundreds of extant or ancestral genomes, we incidentally mapped the functional landscape of mammalian Pol III promoter evolution. Finally, to showcase the usefulness of these parts, we designed a “ten key” molecular recording array that lacks repetitive subsequences in order to facilitate its one-step assembly in yeast. Upon delivering this 15.8 kb tandem array of promoters and guides to mammalian cells, individual pegRNAs exhibited balanced activities as predicted by the activity of component parts, despite their relocation to a single locus. Looking forward, we anticipate that the diversified parts and variant effect maps reported here can be leveraged for the design, assembly and deployment of synthetic loci encoding arrays of gRNAs exhibiting predictable, differentiated levels of activity, which will be useful for multiplex perturbation, advanced biological recorders and complex genetic circuits.
- Top Cited PapersOpen Access
- 14 February 2024
- Published by Springer Nature in Nature
- Vol. 626 (8001) , 1084-1093
A single-cell time-lapse of mouse prenatal development from gastrula to birth
The house mouse (Mus musculus) is an exceptional model system, combining genetic tractability with close evolutionary affinity to humans1,2. Mouse gestation lasts only 3 weeks, during which the genome orchestrates the astonishing transformation of a single-cell zygote into a free-living pup composed of more than 500 million cells. Here, to establish a global framework for exploring mammalian development, we applied optimized single-cell combinatorial indexing3 to profile the transcriptional states of 12.4 million nuclei from 83 embryos, precisely staged at 2- to 6-hour intervals spanning late gastrulation (embryonic day 8) to birth (postnatal day 0). From these data, we annotate hundreds of cell types and explore the ontogenesis of the posterior embryo during somitogenesis and of kidney, mesenchyme, retina and early neurons. We leverage the temporal resolution and sampling depth of these whole-embryo snapshots, together with published data4–8 from earlier timepoints, to construct a rooted tree of cell-type relationships that spans the entirety of prenatal development, from zygote to birth. Throughout this tree, we systematically nominate genes encoding transcription factors and other proteins as candidate drivers of the in vivo differentiation of hundreds of cell types. Remarkably, the most marked temporal shifts in cell states are observed within one hour of birth and presumably underlie the massive physiological adaptations that must accompany the successful transition of a mammalian fetus to life outside the womb.
- 14 February 2024
- Published by Springer Nature in Nature
- Vol. 626 (8001) , 1084-1093
Top Cited PapersOpen AccessA single-cell time-lapse of mouse prenatal development from gastrula to birth
The house mouse (Mus musculus) is an exceptional model system, combining genetic tractability with close evolutionary affinity to humans1,2. Mouse gestation lasts only 3 weeks, during which the genome orchestrates the astonishing transformation of a single-cell zygote into a free-living pup composed of more than 500 million cells. Here, to establish a global framework for exploring mammalian development, we applied optimized single-cell combinatorial indexing3 to profile the transcriptional states of 12.4 million nuclei from 83 embryos, precisely staged at 2- to 6-hour intervals spanning late gastrulation (embryonic day 8) to birth (postnatal day 0). From these data, we annotate hundreds of cell types and explore the ontogenesis of the posterior embryo during somitogenesis and of kidney, mesenchyme, retina and early neurons. We leverage the temporal resolution and sampling depth of these whole-embryo snapshots, together with published data4–8 from earlier timepoints, to construct a rooted tree of cell-type relationships that spans the entirety of prenatal development, from zygote to birth. Throughout this tree, we systematically nominate genes encoding transcription factors and other proteins as candidate drivers of the in vivo differentiation of hundreds of cell types. Remarkably, the most marked temporal shifts in cell states are observed within one hour of birth and presumably underlie the massive physiological adaptations that must accompany the successful transition of a mammalian fetus to life outside the womb.